AT224733T - Precursor compositions neurotransmitter for the treatment of peripheral neuropathy, the antidepressant compounds and / or monoamine oxidase inhibitors and / or vitamin B12 and / or or inducers include - Google Patents

Precursor compositions neurotransmitter for the treatment of peripheral neuropathy, the antidepressant compounds and / or monoamine oxidase inhibitors and / or vitamin B12 and / or or inducers include

Info

Publication number
AT224733T
AT224733T AT97930634T AT97930634T AT224733T AT 224733 T AT224733 T AT 224733T AT 97930634 T AT97930634 T AT 97930634T AT 97930634 T AT97930634 T AT 97930634T AT 224733 T AT224733 T AT 224733T
Authority
AT
Austria
Prior art keywords
neurotransmitter
treatment
vitamin b12
peripheral neuropathy
monoamine oxidase
Prior art date
Application number
AT97930634T
Other languages
German (de)
Inventor
Andrew Peter Worsley
Original Assignee
Wwk Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9614121.3A priority Critical patent/GB9614121D0/en
Priority to GBGB9616019.7A priority patent/GB9616019D0/en
Application filed by Wwk Trust filed Critical Wwk Trust
Priority to PCT/GB1997/001822 priority patent/WO1998001157A1/en
Publication of AT224733T publication Critical patent/AT224733T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AT97930634T 1996-07-05 1997-07-04 Precursor compositions neurotransmitter for the treatment of peripheral neuropathy, the antidepressant compounds and / or monoamine oxidase inhibitors and / or vitamin B12 and / or or inducers include AT224733T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9614121.3A GB9614121D0 (en) 1996-07-05 1996-07-05 Combined medicament
GBGB9616019.7A GB9616019D0 (en) 1996-07-05 1996-07-31 Combined medicaments
PCT/GB1997/001822 WO1998001157A1 (en) 1996-07-05 1997-07-04 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter

Publications (1)

Publication Number Publication Date
AT224733T true AT224733T (en) 2002-10-15

Family

ID=26309637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930634T AT224733T (en) 1996-07-05 1997-07-04 Precursor compositions neurotransmitter for the treatment of peripheral neuropathy, the antidepressant compounds and / or monoamine oxidase inhibitors and / or vitamin B12 and / or or inducers include

Country Status (10)

Country Link
US (1) US6335323B2 (en)
EP (1) EP0942751B1 (en)
AT (1) AT224733T (en)
AU (1) AU3451797A (en)
CA (1) CA2259010A1 (en)
DE (2) DE69715899D1 (en)
DK (1) DK0942751T3 (en)
ES (1) ES2184111T3 (en)
PT (1) PT942751E (en)
WO (1) WO1998001157A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
GB9617990D0 (en) 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
GB9904252D0 (en) * 1999-02-24 1999-04-21 Worsley Andrew P Composition for the treatment of pain
US6575147B2 (en) * 1999-02-25 2003-06-10 Go-Tec Internal combustion system adapted for use of a dual fuel composition including acetylene
GB9906808D0 (en) * 1999-03-24 1999-05-19 Kilgowan Limited Formulation for treatment of pain
US6759437B2 (en) 1999-10-04 2004-07-06 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity including cysteine
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
MXPA04009123A (en) * 2002-03-21 2005-09-08 C Hinz Martin Serotonin and catecholamine system segment optimization techonology.
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
CA2516653A1 (en) * 2003-02-21 2004-09-10 Martin C. Hinz Serotonin and catecholamine system segment optimization technology
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP4638685B2 (en) * 2003-06-10 2011-02-23 ハイデルベルガー ドルツクマシーネン アクチエンゲゼルシヤフトHeidelberger Druckmaschinen AG Method of metering dampening water during printing on an offset press
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
WO2007088473A2 (en) * 2006-02-03 2007-08-09 Neurocure Ltd Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
ES2533484T3 (en) 2007-04-18 2015-04-10 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
EA022007B1 (en) 2009-09-11 2015-10-30 Пробиодруг Аг Heterocylcic derivatives as inhibitors of glutaminyl cyclase
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
JP5688745B2 (en) 2010-03-10 2015-03-25 プロビオドルグ エージー Heterocyclic inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (en) 2011-03-16 2016-05-17 Probiodrug Ag Benzimidazole derivatives as glutaminyl cyclase inhibitors
GB2544630A (en) * 2015-11-19 2017-05-24 The Wwk Trust Combinations for the treatment of dementia, and the enhancement of cognitive function
EP3461819A1 (en) 2017-09-29 2019-04-03 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981863A (en) * 1975-02-25 1976-09-21 Micromedic Diagonistics, Inc. Cyanocobalamin derivatives
US4431670A (en) 1980-12-19 1984-02-14 Bernardo Heller D-Phenylalanine treatment
US4652559A (en) 1982-08-16 1987-03-24 The Upjohn Company 2-(Phenylmethylene)cycloalkyl-azetidines
ES2184808T3 (en) * 1994-10-05 2003-04-16 Cari Loder Treatment of multiple sclerosis (ms) and other demelinizing states using lofepramine in combination with l-phenylalanine, thyrosine or triptophan and optionally a vitamin b12 composite.

Also Published As

Publication number Publication date
DE69715899T2 (en) 2003-05-28
WO1998001157A1 (en) 1998-01-15
ES2184111T3 (en) 2003-04-01
DK942751T3 (en)
AU3451797A (en) 1998-02-02
DK0942751T3 (en) 2002-12-02
DE69715899D1 (en) 2002-10-31
PT942751E (en) 2003-02-28
EP0942751B1 (en) 2002-09-25
EP0942751A1 (en) 1999-09-22
US6335323B2 (en) 2002-01-01
CA2259010A1 (en) 1998-01-15
US20010008884A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
DE69429438T2 (en) Tricyclic carbamate derivatives for inhibition of G-protein function and for the treatment of proliferative diseases
AT13422T (en) Derivatives of 1-aryl-2-aminomethyl-cyclopropanecarboxamides (z), their preparation and their use in the central nervous system for the treatment of disorders.
DE69111642D1 (en) Gabapentin and its derivatives for the treatment of neurodegenerative diseases.
PE110899A1 (en) Hydroxamic acids derived from ariloxiarilsulfonilamino
IS4567A (en) New taxoids, processes for their preparation and pharmaceutical compositions containing them
DE69704877T2 (en) Use of anti-microtubule agents for the treatment and prophylaxis of multiple sclerosis
AT220400T (en) Tricyclic compounds for treatment of cell proliferative disorders
AT87028T (en) Phosphitesterzubereitungen and lubricants and functional fluids containing these.
AT204723T (en) The prosthetic element for the treatment of fractures afford, particularly for coelioskopie
SE0203752D0 (en) New compounds
ES2178668T4 (en) Naftilamids as agents of the central nervous system.
DE69430440D1 (en) Compositions for the inhibition of retroviral proliferation, and hydroxyurea containing 2 ', 3'-dideoxy-inosine
DE68922319D1 (en) Bioabsorbable surgical material for the treatment of nerve defects and method for its preparation.
DE69510696T2 (en) 2- (2-amino-3-methoxyphenyl) -4-oxo-4H- (1) -benzopyran diseases for the treatment of proliferative
DE3850358D1 (en) Treatment and post-treatment of metals by means of polyphenol compounds.
DE1073432T1 (en) Using glycinrezeptoragonisten and glycinaufnahmeinhibitoren for treatment of neuropsychiatric complaints
AT97805T (en) Composition and method for treating diseases.
AT224375T (en) 4,5-substituted imidazolyl compounds for the treatment of inflammation
DE69110561T2 (en) Agents for the treatment and prevention of abdominal inflammation, comprising as active ingredient zinc L-carnosine salts or complexes.
DE69324684D1 (en) Drugs for the treatment of arthritis, the phosphonates and nsaids included
DE69404039T2 (en) Second amine as antidiabetic agents and for the treatment of obesity
DE69802260T2 (en) Pharmaceutical compositions containing the Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections
AT141242T (en) flow method for the treatment of aqueous, undesirable amounts of cyanide-containing
AT41143T (en) Acrylate and fungicides which contain these compounds.
RU95104885A (en) 1h-indole-3-glyoxylamides inhibiting spla2-mediated fatty acids release, pharmaceutical composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0942751

Country of ref document: EP

REN Ceased due to non-payment of the annual fee